Last reviewed · How we verify

Perindopril + amlodipine + if necessary, hydrochlorothiazide — Competitive Intelligence Brief

Perindopril + amlodipine + if necessary, hydrochlorothiazide (Perindopril + amlodipine + if necessary, hydrochlorothiazide) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: ACE inhibitor + calcium channel blocker + thiazide diuretic combination. Area: Cardiovascul

marketed ACE inhibitor + calcium channel blocker + thiazide diuretic combination Angiotensin-converting enzyme (ACE), L-type calcium channels, sodium-chloride cotransporter Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Perindopril + amlodipine + if necessary, hydrochlorothiazide (Perindopril + amlodipine + if necessary, hydrochlorothiazide) — Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company. This combination reduces blood pressure by blocking angiotensin II formation (perindopril), relaxing blood vessel smooth muscle (amlodipine), and reducing fluid volume (hydrochlorothiazide).

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Perindopril + amlodipine + if necessary, hydrochlorothiazide TARGET Perindopril + amlodipine + if necessary, hydrochlorothiazide Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company marketed ACE inhibitor + calcium channel blocker + thiazide diuretic combination Angiotensin-converting enzyme (ACE), L-type calcium channels, sodium-chloride cotransporter

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (ACE inhibitor + calcium channel blocker + thiazide diuretic combination class)

  1. Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Perindopril + amlodipine + if necessary, hydrochlorothiazide — Competitive Intelligence Brief. https://druglandscape.com/ci/perindopril-amlodipine-if-necessary-hydrochlorothiazide. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: